BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Revenue

BioRestorative Therapies had revenue of $89.10K in the quarter ending June 30, 2024, with 38.14% growth. This brings the company's revenue in the last twelve months to $174.10K, up 35.49% year-over-year. In the year 2023, BioRestorative Therapies had annual revenue of $145.80K with 21.70% growth.

• Revenue (ttm): $174.10K
• Revenue Growth: +35.49%
• P/S Ratio: 57.02
• Revenue / Employee: $15,827
• Employees: 11
• Market Cap: 11.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	145.80K	26.00K	21.70%
Dec 31, 2022	119.80K	73.80K	160.43%
Dec 31, 2021	46.00K	-31.00K	-40.26%
Dec 31, 2020	77.00K	-53.00K	-40.77%
Dec 31, 2019	130.00K	19.00K	17.12%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.